We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNCN
4326
DELISTED
BNC Bancorp
BNCN
$185K ﹤0.01%
5,292
+3,871
+272% +$134K
CALM icon
4327
CALL
Cal-Maine
CALM
$4.08B
$184K ﹤0.01%
5,000
-11,000
-69% -$440K
DIOD icon
4328
Diodes
DIOD
$3.77B
$184K ﹤0.01%
7,654
+6,051
+377% +$151K
LEA icon
4329
PUT
Lear
LEA
$6.17B
$184K ﹤0.01%
1,300
-8,900
-87% -$1.26M
ORMP icon
4330
Oramed Pharmaceuticals
ORMP
$180M
$184K ﹤0.01%
29,925
WAC
4331
DELISTED
Walter Investment Mgt Corp
WAC
$184K ﹤0.01%
170,793
+147,733
+641% +$455K
FNFV
4332
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$184K ﹤0.01%
13,846
+11,238
+431% +$141K
AXDX
4333
DELISTED
Accelerate Diagnostics
AXDX
$183K ﹤0.01%
757
-120
-14% -$27.4K
BBBY
4334
Bed Bath & Beyond
BBBY
$507M
$183K ﹤0.01%
14,089
+8,100
+135% +$106K
LXRX icon
4335
Lexicon Pharmaceuticals
LXRX
$1.03B
$183K ﹤0.01%
12,730
-18,084
-59% -$268K
VSTO
4336
DELISTED
Vista Outdoor Inc.
VSTO
$182K ﹤0.01%
8,830
-91,045
-91% -$2.25M
NPO icon
4337
Enpro
NPO
$7.06B
$181K ﹤0.01%
2,549
+1,887
+285% +$125K
PFX icon
4338
PhenixFIN
PFX
$83.1M
$181K ﹤0.01%
+1,177
New +$180K
ENZ
4339
DELISTED
Enzo Biochem, Inc.
ENZ
$181K ﹤0.01%
21,546
-57,454
-73% -$405K
HABT
4340
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$181K ﹤0.01%
10,189
-2,181
-18% -$33.2K
NCI
4341
DELISTED
Navigant Consulting, Inc.
NCI
$181K ﹤0.01%
7,926
+6,114
+337% +$146K
INDB icon
4342
Independent Bank
INDB
$4.05B
$180K ﹤0.01%
2,769
+1,915
+224% +$124K
LOCO icon
4343
CALL
El Pollo Loco
LOCO
$504M
$180K ﹤0.01%
15,100
-13,500
-47% -$166K
POWI icon
4344
Power Integrations
POWI
$3.37B
$180K ﹤0.01%
5,470
+3,270
+149% +$109K
TVTX icon
4345
Travere Therapeutics
TVTX
$5.11B
$180K ﹤0.01%
9,792
-8,649
-47% -$169K
SEE
4346
CALL
DELISTED
Sealed Air
SEE
$179K ﹤0.01%
4,100
+2,100
+105% +$98.7K
LTC
4347
LTC Properties
LTC
$1.99B
$178K ﹤0.01%
3,694
-7,535
-67% -$353K
ROST icon
4348
PUT
Ross Stores
ROST
$81.1B
$178K ﹤0.01%
2,700
-16,600
-86% -$1.11M
NUAN
4349
PUT
DELISTED
Nuance Communications, Inc.
NUAN
$178K ﹤0.01%
11,897
-15,361
-56% -$219K
BMCH
4350
DELISTED
BMC Stock Holdings, Inc
BMCH
$178K ﹤0.01%
7,902
+7,071
+851% +$143K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.